Modified Treatment for Epidemic Keratoconjunctivitis (EKC)

• Status: Completed
• Trial end date: 2018-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Background: Epidemic Keratoconjunctivitis (EKC) is a form of adenoviral conjunctivitis. It is highly infectious disease mainly affect the outer eye surface and has a frequency to happen in epidemics especially in closed communities such as hospitals, schools and factories.

purpose: The purpose of this study to compare between the modified and the ordinary method of treatment for EKC.

Patients and methods: Three hundred fifty patients of EKC were enrolled in the study. The diagnosis was made by clinical picture and laboratory investigations. Group 1 had two hundred patients 120 males, 80 females (age from 18 to 60 years) were treated by the modified method and group 2 had one hundred fifty patients 100 males,50 females (age from 18 to 58 years) were treated with the ordinary method. The study was hold between November 2014 to October 2018 in Security forces Hospital, Riyadh, Saudi Arabia. Patients were followed up for 3 months up to 2 years. The main outcome were improvement in clinical picture and recovery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Minia University
• Treatments: Iodine; Povidone; Povidone-Iodine

Criteria

Inclusion Criteria:

• Including adult patients with 18 to 60 years old

• Patients with BCDVA of ≥ 20/80 in the study eye

• If the patent have bilateral EKC only one eye included in the study

• Patients attending all the required follow up visits as advised.

Exclusion Criteria:

• Children

• Patients with ocular infection rather than EKC

• Patients with corneal ulceration or bacterial keratitis

• Immunocompromised patients

• Glaucoma

• Patients not attending the required follow up visits.